stockrow
Friday 6 November 2026
Export PRPO’s income statement to Excel — free account
Precipio, Inc.
PRPO Healthcare Diagnostics & Research
Precipio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $24.0 million, up 29.8% from fiscal 2024.
- Revenue
- +24.2%
- EPS
- −340.0%
- Free cash flow
- +79.6%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
18.95
0.36
+1.94%
Follow PRPO
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.63 | 1.73 | 1.53 | 1.28 | |
P/FCF ratio |
56.09 | 80.32 | 102.74 | 49.46 | |
P/Operating CF |
67.05 | 696.52 | 100.78 | 2,913.11 | |
P/B ratio |
3.00 | 3.15 | 2.53 | 2.12 | |
Price to Tangible BV |
10.26 | 12.79 | 10.13 | 11.24 | |
EV/Sales |
1.55 | 1.65 | 1.46 | 1.22 | |
EV/EBITDA |
142.41 | 1,709.78 | 63.40 | 0.00 | |
EV/Operating CF |
38.32 | 53.90 | 51.19 | 31.35 | |
EV/FCF |
53.43 | 77.02 | 97.67 | 47.05 | |
Quick Ratio |
1.45 | 1.21 | 1.24 | 0.96 | |
Current Ratio |
1.77 | 1.56 | 1.61 | 1.27 | |
Net Debt/EBITDA |
16.15 | 1.89 | (1.79) | (3.77) | |
Debt/Assets |
4.58% | 3.71% | 3.88% | 4.18% | |
Debt/Equity |
0.07 | 0.05 | 0.06 | 0.06 | |
Asset Turnover |
1.36 | 1.34 | 1.26 | 1.20 | |
Operating CF/Net income |
(3.01) | (0.04) | 0.70 | (0.13) | |
Capex/Depreciation |
(0.28) | (0.11) | (0.16) | (0.12) | |
Interest Coverage |
(66.56) | (95.20) | 33.88 | (6.78) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.49 | 0.51 | 0.51 | 0.53 | |
Share Based Compensation of Revenue |
10.92% | 14.80% | 1.57% | 3.43% | |
Graham Net Nets |
0.00 | (0.02) | (0.02) | (0.06) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.58%) | (1.88%) | (1.09%) | (4.61%) | |
Free Cash Flow Yield |
1.78% | 1.25% | 0.97% | 2.02% | |
Revenue per Share |
3.93 | 3.76 | 4.17 | 4.13 | |
Operating CF per Share |
0.37 | 0.04 | 0.23 | 0.01 | |
Capex per Share |
(0.07) | (0.03) | (0.05) | (0.03) | |
Free Cash Flow per Share |
0.30 | 0.01 | 0.18 | (0.03) | |
Cash per Share |
1.72 | 1.46 | 1.65 | 1.41 | |
Shareholders Equity per Share |
8.26 | 7.95 | 9.07 | 8.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.26 | 7.95 | 9.07 | 8.40 | |
Free Cash Flow |
0.53 | 0.01 | 0.29 | (0.04) | |
Working Capital |
2.84 | 2.12 | 2.29 | 1.22 | |
Capital Expenditures |
(0.13) | (0.05) | (0.07) | (0.05) | |
Net Current Asset Value |
(0.03) | (0.70) | (0.72) | (1.74) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.88 | 1.48 | 1.39 | 1.49 | |
Average Payables |
1.07 | 1.13 | 0.87 | 0.92 | |
Average Inventory |
0.92 | 0.85 | 0.83 | 0.69 | |
Average Assets |
20.07 | 19.29 | 19.16 | 19.05 | |
Average Common Equity |
13.52 | 12.93 | 13.33 | 12.85 |
Columns are period end dates · fundamentals updated 26 Oct 2026